Researcher
Marc Jacquemin
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From23 Nov 2000 → Today
Projects
1 - 5 of 5
- Rapid and easy-to-perform FO-SPR-based assays for VWF antigen and functionality and insights into the vaccine-induced adaptive immune response against SARS-CoV-2From1 Aug 2019 → 25 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Addition of ImageStream facilities to the FACS CoreFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Cellular Interactions and Heterogeneity in Ischemic Cardiovascular DiseaseFrom1 Nov 2010 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
- Development of an innovative platform for generation of tailor-made fully human therapeutic monoclonal antibodies against human targetsFrom1 Jan 2010 → 31 Dec 2013Funding: SBO (Strategic basic research)
- PharmAbs: K.U.Leuven Antibody Center.From1 Sep 2009 → TodayFunding: IOF - Industrial Research Fund, IOF - mandates
Publications
31 - 40 of 71
- The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders(2015)
Authors: Marijke Peetermans, Jaan Toelen, Joke Schoeters, Kathelijne Peerlinck, Joanne van Ryn, Thomas Vanassche, Peter Verhamme, Marc Jacquemin
Pages: 394 - 394 - The type of reagents determines the accuracy of calibration with a product specific standard for the measurement of the B-domain deleted RFVIII Moroctocog alfa-AF activity(2015)
Authors: Marc Jacquemin, A Vodolazkaia, E Heylen, Jaan Toelen, J Schoeters, Kathelijne Peerlinck
Pages: 560 - 560 - Free hemoglobin: a boost to platelet thrombi(2015)
Authors: Marc Jacquemin, Kathelijne Peerlinck
Pages: 2262 - 2263 - The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders(2015)
Authors: Marc Jacquemin, Jaan Toelen, Marijke Peetermans, Thomas Vanassche, Kathelijne Peerlinck, Peter Verhamme
Pages: 2087 - 2092 - Factor VIII inhibitor: affinity is the clue(2015)
Authors: Marc Jacquemin, Kathelijne Peerlinck
Pages: 1056 - 1058 - Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII(2014)
Authors: Kris Covens, Kathelijne Peerlinck, Marc Jacquemin
Pages: 36 - 42 - Response: Extended analysis of microarray data does not contradict preplasmablast phenotype of human CD20+CD27+CD43+ cells(2013)
Authors: Kris Covens, Bert Verbinnen, Marc Jacquemin, Xavier Bossuyt
Pages: 3693 - 4 - Calibration of the X-Ray Photoelectron Spectroscopy Binding Energy Scale for the Characterization of Heterogeneous Catalysts: Is Everything Really under Control?(2013)
Authors: Marc Jacquemin
Pages: 3618 - 3626 - Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial.(2013)
Authors: Lieve Goossens, Philip Moons, Johny Verschakelen, Kathelijne Peerlinck, Marc Jacquemin
Pages: 1892 - 1899 - Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomized, non-inferiority, open trial(2013)
Authors: Lieve Goossens, Willy Peetermans, Steffen Fieuws, Philip Moons, Johny Verschakelen, Marc Jacquemin, Marguerite Stas
Pages: 1892 - 1899